Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Cash Flows

v3.20.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss $ (12,474) $ (39,252)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 82 85
Stock-based compensation expense 1,220 1,387
Accretion of investments discount 0 (61)
Amortization of debt issuance costs and discount 910 879
Warrant liabilities fair value adjustment (16,114) 2,643
Change in fair value of derivative liabilities (6,683) (223)
Noncash operating lease expense for right-of-use asset 144 127
Loss on extinguishment of debt 806 1,045
Noncash consideration associated with common stock purchase agreement 602 0
Changes in operating assets and liabilities:    
Prepaid expenses, other assets, deferred costs, and other 1,482 6,485
Accounts payable, accrued expenses, and other (2,757) 2,345
Deferred revenue 0 (121)
Net cash used in operating activities (32,782) (24,661)
Cash flows from investing activities:    
Maturities of investments 20,713 54,700
Purchases of property and equipment (4) 0
Purchases of investments (14,235) (38,504)
Net cash provided by investing activities 6,474 16,196
Cash flows from financing activities:    
Proceeds from common stock issued 4,702 10,069
Payments of offering costs and underwriting discounts and commissions (279) (302)
Proceeds from common stock issuance under employee stock purchase plan 28 49
Repurchase of shares to satisfy tax withholdings (75) 0
Proceeds from senior convertible notes 10,000 16,000
Payments of senior convertible notes issuance costs (494) (1,253)
Payment of loan payable expected to be refinanced 0 (15,973)
Net cash provided by financing activities 13,882 8,590
Net (decrease) increase in cash, cash equivalents, and restricted cash (12,426) 125
Cash, cash equivalents, and restricted cash at beginning of period 42,193 11,767
Cash, cash equivalents, and restricted cash at end of period 29,767 11,892
Supplemental cash flow information:    
Cash paid for interest 840 850
Cash received for interest 186 736
Noncash financing and investing activities:    
Operating lease liabilities arising from obtaining right-of-use assets 0 3,365
Deferred offering costs reclassified to additional-paid-in capital 1 6
Common stock issued for settlement of senior convertible notes 2,784 2,984
Deferred offering and issuance costs included in accounts payable and accrued expenses 54 0
Common stock issued for Commitment Shares $ 602 $ 0